E-Book

Nasal Delivery Technology, Quality By Design Processes And Outsourcing Considerations

Source: Catalent
GettyImages-1312594792-inhalation-lung

Catalent leverages decades of experience in the development, evaluation and manufacture of inhalation products to advance and accelerate molecules, from early development through commercial manufacturing. Catalent’s operation integrates its knowledge and experience to reliably deliver therapies across all common inhalation dosage forms including MDI, DPI and nasal sprays.

This eBook features articles discussing the advantages of unit/bi-dose nasal delivery technology, application of quality by design (QbD) process for inhaled product development and why companies are looking to outsource inhalation development and manufacturing.

VIEW THE E-BOOK!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online